{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:34Z","timestamp":1792794814901,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.072","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T14:58:18Z","timestamp":1659797898000},"page":"5391-5398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9\u00a0months to 15\u00a0years in Sindh, Pakistan"],"prefix":"10.1016","volume":"40","author":[{"given":"Rozina S.","family":"Thobani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Tahir","family":"Yousafzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Momin","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Rafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0473-2992","authenticated-orcid":false,"given":"Ayub","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram Uddin","family":"Ujjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-0436","authenticated-orcid":false,"given":"Nick","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Naz","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.072_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijid.2005.03.010","article-title":"Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan","volume":"10","author":"Siddiqui","year":"2006","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.072_b0010","first-page":"260","article-title":"Clinical pathogenesis of typhoid fever","volume":"2","author":"Raffatellu","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2022.06.072_b0015","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2022.06.072_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low and middle-income countries: a meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.06.072_b0025","article-title":"World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis","volume":"12","author":"Kirk","year":"2015","journal-title":"PLOS Med"},{"key":"10.1016\/j.vaccine.2022.06.072_b0030","doi-asserted-by":"crossref","unstructured":"Ochiai RL et al. Domi Typhoid Study Group. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008;86:260\u2013268.","DOI":"10.2471\/BLT.06.039818"},{"key":"10.1016\/j.vaccine.2022.06.072_b0035","unstructured":"SAGE Working Group on Typhoid Vaccines & the WHO Secretariat. Background paper on typhoid vaccines for SAGE meeting (October 2017). Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_Typhoid_SAGE_background_paper_Final_v3B.pdf [accessed 22 February 2019]."},{"key":"10.1016\/j.vaccine.2022.06.072_b0040","unstructured":"Gavi The Vaccine Alliance. Pakistan becomes first country to introduce new typhoid vaccine into routine immunisation program; 2019. Available at: https:\/\/www.gavi.org\/news\/media-room\/pakistan-becomes-first-country-introduce-new-typhoid-vaccine-routine-immunisation#:~:text=Pakistan%20becomes%20first%20country%20to%20introduce%20new%20typhoid,vaccine%20to%20offer%20protection%20against%20increasingly%20drug-resistant%20disease [accessed25 February 2020]."},{"key":"10.1016\/j.vaccine.2022.06.072_b0045","unstructured":"World Health Organization (WHO). Guidelines on the quality, safety, and efficacy of typhoid conjugate vaccines. Available at: http:\/\/www.who.int\/biologicals\/areas\/vaccines\/TYPHOID_BS2215_doc_v1.14_WEB_VERSION.pdf?ua=1&ua=1 [accessed on 23\/12\/2016]."},{"key":"10.1016\/j.vaccine.2022.06.072_b0050","doi-asserted-by":"crossref","unstructured":"Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R, Chilean Typhoid Committee. Progress in vaccines against typhoid fever. Clinical Infectious Diseases 1989 May 1;11(Supplement_3):S552\u201367.","DOI":"10.1093\/clinids\/11.Supplement_3.S552"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.072_b0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s100960050361","article-title":"Experience with Salmonella typhi Vi capsular polysaccharide vaccine","volume":"18","author":"Hessel","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.072_b0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.072_b0065","article-title":"Vaccines for preventing typhoid fever","volume":"5","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.072_b0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.072_b0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.072_b0080","doi-asserted-by":"crossref","unstructured":"Meiring JE, Gibani M, Basnyat B, Bentsi-Enchill AD, Clemens J, Darton TC, et al The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26\u201327 October 2016, Oxford, UK. Vaccine. 2017 Sep 12;35(38):5081-8.","DOI":"10.1016\/j.vaccine.2017.08.001"},{"key":"10.1016\/j.vaccine.2022.06.072_b0085","unstructured":"World Bank. World development indicators; 2019. Available at: https:\/\/datacatalog.worldbank.org\/dataset\/world-development-indicators."},{"issue":"9884","key":"10.1016\/j.vaccine.2022.06.072_b0090","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0140-6736(12)61999-0","article-title":"Reproductive, maternal, newborn, and child health in Pakistan: challenges and opportunities","volume":"381","author":"Bhutta","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2022.06.072_b0095","unstructured":"The Demographic and Health Surveys Program; 2017. Demographic and Health Surveys\u2014Pakistan: USAID. Available at: http:\/\/dhsprogram.com\/Where-We-Work\/Country-Main.cfm?ctry_id=31&c=Pakistan&Country=Pakistan&cn=&r=4 [accessed March 2019]."},{"key":"10.1016\/j.vaccine.2022.06.072_b0100","unstructured":"Pakistan Bureau of Statistics. Province wise provisional results of census -2017; 2018."},{"key":"10.1016\/j.vaccine.2022.06.072_b0105","unstructured":"http:\/\/www.emro.who.int\/pak\/pakistan-news\/more-than-94-children-vaccinated-with-typhoid-conjugate-vaccine-in-sindh.html."},{"key":"10.1016\/j.vaccine.2022.06.072_b0110","doi-asserted-by":"crossref","unstructured":"Cohen AL, Taylor Jr T, Farley MM, Schaffner W, Lesher LJ, Gershman KA, et al An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.","DOI":"10.1371\/journal.pone.0041785"},{"key":"10.1016\/j.vaccine.2022.06.072_b0115","unstructured":"Yousafzai MT, Karim S, Qureshi S, Kazi M, Memon H, Junejo A, et al Impact Evaluation of Typhoid Conjugate Vaccine Against Culture-Confirmed Typhoid in Extensively Drug-Resistant Outbreak Setting of Hyderabad, Pakistan."},{"key":"10.1016\/j.vaccine.2022.06.072_b0120","doi-asserted-by":"crossref","unstructured":"Qamar FN, Batool R, Qureshi S, Ali M, Sadaf T, Mehmood J, et al Strategies to improve coverage of typhoid conjugate vaccine (TCV) immunization campaign in Karachi, Pakistan. Vaccines 2020 Dec;8(4):697.","DOI":"10.3390\/vaccines8040697"},{"issue":"23","key":"10.1016\/j.vaccine.2022.06.072_b0125","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2022.06.072_b0130","unstructured":"Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Org 1985;63(6):1055."},{"key":"10.1016\/j.vaccine.2022.06.072_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.08.051","article-title":"Mehmood J et al Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study","author":"Batool","year":"2021","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2022.06.072_b0140","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Feikin DR et al Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.072_b0145","doi-asserted-by":"crossref","unstructured":"Qadri F, Khanam F, Liu X, Theiss-Nyland K, Biswas PK, Bhuiyan AI, et al Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomized trial. The Lancet 2021 Aug 9.","DOI":"10.1016\/S0140-6736(21)01124-7"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.072_b0150","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Mwakiseghile F et al Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.072_b0155","unstructured":"World Health Organization. Antimicrobial resistance. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance [accessed 2 December 2019]."},{"key":"10.1016\/j.vaccine.2022.06.072_b0160","doi-asserted-by":"crossref","unstructured":"Chatham-Stephens K, Medalla F, Hughes M, Appiah GD, Aubert RD, Caidi H, et al Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan\u2014United States, 2016\u20132018. Morbidity and Mortality Weekly Report 2019 Jan 11;68(1):11.","DOI":"10.15585\/mmwr.mm6801a3"},{"key":"10.1016\/j.vaccine.2022.06.072_b0165","doi-asserted-by":"crossref","unstructured":"Yousafzai MT, Irfan S, Thobani RS, Kazi AM, Hotwani A, Memon AM, et al. Burden of culture confirmed enteric fever cases in Karachi, Pakistan: Surveillance for Enteric Fever in Asia Project (SEAP), 2016\u20132019. Clin Infect Dis 2020 Nov 1;71(Supplement_3): S214-21.","DOI":"10.1093\/cid\/ciaa1308"},{"issue":"04","key":"10.1016\/j.vaccine.2022.06.072_b0170","first-page":"253","article-title":"The burden of enteric fever","volume":"2","author":"Kothari","year":"2008","journal-title":"J Infect Dev Countries"},{"key":"10.1016\/j.vaccine.2022.06.072_b0175","doi-asserted-by":"crossref","unstructured":"Saha SK, Baqui AH, Hanif M, Darmstadt GL, Ruhulamin M, Nagatake T, et al. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatric Infect Dis J 2001 May 1;20(5):521-4.","DOI":"10.1097\/00006454-200105000-00010"},{"issue":"10111","key":"10.1016\/j.vaccine.2022.06.072_b0180","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomized controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.072_b0185","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/vaccines8040697","article-title":"Strategies to improve coverage of typhoid conjugate vaccine (TCV) immunization campaign in Karachi, Pakistan","volume":"8","author":"Qamar","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2022.06.072_b0190","doi-asserted-by":"crossref","unstructured":"Bhutta ZA. Integrating typhoid fever within the sustainable development goals: pragmatism or Utopia? Clin Infect Dis 2019 Feb 15;68(Supplement_1):S34-41.","DOI":"10.1093\/cid\/ciy957"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:17:01Z","timestamp":1759403821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008404"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9\u00a0months to 15\u00a0years in Sindh, Pakistan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}